KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $2.54.

  • Elevance Health's EPS (Weighted Average and Diluted) rose 3582.89% to $2.54 in Q4 2025 from the same period last year, while for Dec 2025 it was $25.19, marking a year-over-year decrease of 186.99%. This contributed to the annual value of $25.21 for FY2025, which is 183.02% down from last year.
  • As of Q4 2025, Elevance Health's EPS (Weighted Average and Diluted) stood at $2.54, which was up 3582.89% from $5.32 recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's EPS (Weighted Average and Diluted) peaked at $9.85 during Q2 2024, and registered a low of $1.87 during Q4 2024.
  • In the last 5 years, Elevance Health's EPS (Weighted Average and Diluted) had a median value of $6.66 in 2021 and averaged $6.26.
  • In the last 5 years, Elevance Health's EPS (Weighted Average and Diluted) surged by 60459.77% in 2021 and then tumbled by 4890.71% in 2024.
  • Over the past 5 years, Elevance Health's EPS (Weighted Average and Diluted) (Quarter) stood at $4.86 in 2021, then dropped by 25.72% to $3.61 in 2022, then rose by 1.39% to $3.66 in 2023, then plummeted by 48.91% to $1.87 in 2024, then surged by 35.83% to $2.54 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $2.54 for Q4 2025, versus $5.32 for Q3 2025 and $7.72 for Q2 2025.